Estetrol (E4): The New Estrogenic Component of Combined Oral Contraceptives

Expert Rev Clin Pharmacol. 2020 Apr;13(4):327-330. doi: 10.1080/17512433.2020.1750365. Epub 2020 Apr 7.

Abstract

No abstract available

Keywords: Hormonal contraception; cardiovascular risks; combined hormonal contraceptives; drospirenone; estetrol; estradiol; ethinyl-estradiol; hemostasis; levonorgestrel; metabolism; venous thromboembolic events.

Publication types

  • Editorial